NASDAQ: PDSB · Biotechnology
Over the past week, PDS Biotechnology (PDSB) saw about 51 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 54% bullish across the tracked sources. Wall Street is more constructive, with 3 of 3 analysts rating PDSB a buy.
There is little buzz around PDSB this week and broad agreement on direction, which is why it reads as a Hold.
Wall Street’s 100% buy share sits next to a crowd that ranges from News at 50% to Reddit at 60%. No other tracker puts the two side by side.
3 analysts have weighed in: a Strong Buy consensus: 3 buy calls against 0 sell, with an average 12-month price target of $5.00.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is mixed and the 3 sources broadly agree, so the read is Hold rather than a clear buy or sell.
Analysts sit 46 points above the crowd average of 54%, the professionals are more constructive than retail. The split is inside the crowd: Reddit reads 60% bullish while News sits at 50%, a 10-point spread that single-source trackers miss.
Weekly price context: this Alpha Vantage chart keeps its own dated range; the sentiment metrics elsewhere on this page may be newer. Over the 30-day window, PDS Biotechnology (PDSB) buzz held moderate around 42.6 while the price drifted up 368.0% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 43.5M shares. Updated Oct 10, 2026. Over the last 7 trading days, PDSB gained 95.4%. Buzz activity in the recent week averaged 36.7 and was variable, swinging between 21.9 and 46.6. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 12 of the 17 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for PDSB and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live PDSB sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 12, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (3 / 0 / 0) |
| Crowd bullish (7d) | 54% |
| Avg price target | $5.00 |
| Most bullish source | Reddit, 60% |
| Most bearish source | News, 50% |
| Sentiment spread | 10 pts |
| Mentions (7d) | 51 |
| Market cap | $73.9M |
| EPS · Beta | -$0.64 · 1.2 |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, PDS Biotechnology (PDSB) currently carries an Adanos hold signal with 77/100 conviction. The current cross-source average reads 54% bullish across 3 active sources. Those sources contribute 51 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around PDS Biotechnology (PDSB) is fairly quiet with 10 mentions over the last 7 days; the 30-day context spans 6 tracked subreddits. The 7-day tone is 60% bullish; 3-day activity momentum is falling, suggesting cooling attention.
The crowd reads split on PDS Biotechnology (PDSB), averaging 54% bullish across 3 tracked sources over the last 7 days. The two ends of the range are Reddit at 60% bullish and News at 50%, a 10-point spread. On the professional side, 3 of 3 analysts rate PDSB a buy.
Of the 3 analysts covering PDS Biotechnology (PDSB), 3 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $5.00. That puts the street ahead of the crowd, which averages 54% bullish.
PDS Biotechnology (PDSB)'s cross-source average is mixed at 54% bullish. Source readings are split: 2 sources lean bullish and 1 source sits at 50% bullish. Reddit reads 60% bullish, X reads 51% bullish and news coverage is the most negative at 50% bullish. The combined signal points to broad mixed pressure with 77/100 conviction.
The cross-source average is mixed for PDS Biotechnology (PDSB) at 54% bullish. Source readings are split: 2 sources lean bullish and 1 source sits at 50% bullish. The most bearish reading is news at 50% bullish. 3-day activity momentum is falling on Reddit, while x activity is rising. The hold signal carries 77/100 conviction.
X is the dominant discussion channel with 39 mentions (76% of total volume). Reddit contributes 10 mentions and News contributes 2 mentions. The cross-source average is mixed at 54% bullish, while x is the only source with rising 3-day activity. Source readings are split: 2 sources lean bullish and 1 source sits at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. PDSB's hold signal at 77/100 conviction reflects a mixed cross-source average at 54% bullish. Source readings are split: 2 sources lean bullish and 1 source sits at 50% bullish. It is a research shortcut, not financial advice.
The PDSB sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key